4//SEC Filing
Burrows Scott L 4
Accession 0000950170-24-010901
CIK 0001636282other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:27 PM ET
Size
5.5 KB
Accession
0000950170-24-010901
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+70,000→ 70,000 totalExercise: $25.86Exp: 2034-02-01→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]This option a right to purchase 70,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001853327
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:27 PM ET
- Size
- 5.5 KB